Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1248-1261, May 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyasu, R.
Right arrow Articles by Hass, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyasu, R.
Right arrow Articles by Hass, G. M.

Induction of Cerebral Gliomas in Rats with Dietary Lead Subacetate and 2-Acetylaminofluorene1

Ryoichi Oyasu2, Hector A. Battifora2, Raymond A. Clasen, James H. McDonald and George M. Hass

Division of Pathology, Presbyterian-St. Luke's Hospital, Chicago, Illinois 60612

In a study of neoplasms induced by 2-acetylaminofluorene (2-AAF) and lead subacetate, 25 gliomas and 3 extracerebral intracranial tumors were found in 988 Wistar and cesarean-delivered (Sprague-Dawley) rats, of which 663 were in experimental and 325 in control groups. The tumors usually developed after 52 weeks of age. Most tumors were classified as poorly differentiated malignant gliomas. The highest incidence (8.6%) of gliomas was in animals ingesting lead subacetate and the difference compared with the incidence (0.3%) among controls was statistically significant (p < 0.05). In animals given 2-AAF with or without oliver oil, carbon tetrachloride, or ethionine, the incidence (2.5%) of gliomas was lower and their development was usually delayed until after 60 weeks of age but the incidence (5.5%) among rats that survived 60 weeks or more was statistically significant (p < 0.05) when compared with that of 325 control rats in which only 1 glioma was found. Unsuccessful attempts were made to increase the incidence of gliomas by combining lead subacetate with 2-AAF management and by local freezing of the brain in the early stage of prolonged 2-AAF dietary treatment.

1 This work was supported by Grants 2G-129, NB 04872, NB 03677, CA 05378, and CA 11036 from NIH, USPHS, and the Grant H. Laing Research Funds.

2 USPHS Postdoctoral Research Trainee in Pathology 2G-129.

Received 8/ 8/69. Accepted 11/12/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.